×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
概览
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena. Attendees from the different CMC (chemistry, manufacturing and controls) areas will be able to interact with peers from Regulatory Agencies and Industry in sessions enabling interactive cross-functional discussions.
This program was developed by the CMC Working Group of the DIA Regulatory Affairs Community.
项目委员会
-
Yasmin de Faria Krim, PharmD, MSc CMC working group
Chair, CMC Working Group, DIA Regulatory Affairs Community, France -
Ursula Busse, PhD, MBA Head of Regulatory Affairs
Tigen Pharma SA, Switzerland -
Sabine Kopp, PhD Group Lead, Medicines Quality Assurance
World Health Organization (WHO), Switzerland -
Frank Montgomery, PhD Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom -
Elaine Morefield, PhD, RPh Vice President, Regulatory Affairs
VaxForm, LLC., United States -
Moheb M. Nasr, PhD, MS Principal
Nasr Pharma Regulatory Consulting, United States -
Peter Richardson, PhD Head of Quality, Specialised Scientific Disciplines Department
European Medicines Agency, Netherlands -
Jean-Louis Robert, PhD Former CHMP/CVMP QWP Chair
Luxembourg